首页> 外文OA文献 >Expression of an anti-CD4 single-chain antibody fragment from the donor cornea can prolong corneal allograft survival in inbred rats
【2h】

Expression of an anti-CD4 single-chain antibody fragment from the donor cornea can prolong corneal allograft survival in inbred rats

机译:来自供体角膜的抗CD4单链抗体片段的表达可延长近交系大鼠角膜移植物的存活时间

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To investigate whether expression of an anti-CD4 antibody fragment (scFv) by a lentivector-transduced donor cornea can prolong rat corneal allograft survival. METHODS: Inbred Fischer 344 rats received penetrating corneal allografts from Wistar-Furth donors after a 3 h transduction of the donor cornea with a lentivector carrying anti-CD4scFv cDNA (Lv-CD4scFv), a lentivector carrying the reporter gene-enhanced yellow fluorescence protein (LV-eYFP), or an adenoviral vector carrying anti-CD4 scFv cDNA (Ad-CD4scFv). Unmodified controls were also performed. Graft survival was assessed by corneal clarity, and rejection was confirmed histologically. RESULTS: In organ-cultured corneas, expression of anti-CD4 scFv was detected at 2 days post-transduction with the adenoviral vector, compared with 5 days post-transduction with the lentivector, and was 10-fold higher than the former. More inflammation was observed in Ad-CD4scFv-modified allografts than in Lv-CD4scFv-modified grafts at 15 days postsurgery (p=0.01). The median time to rejection for unmodified, LV-eYFP and Ad-CD4scFv grafts was day 17, compared with day 22 for Lv-CD4scFv grafts (p≤0.018). CONCLUSION: Donor corneas transduced with a lentiviral vector carrying anti-CD4scFv cDNA showed a modest but significant prolongation in graft survival compared with unmodified, Lv-eYFP and Ad-CD4scFv grafts. However, rejection still occurred in all Lv-CD4scFv grafts, indicating that sensitisation may have been delayed but was not prevented.
机译:目的:研究通过慢载体转导的供体角膜表达抗CD4抗体片段(scFv)是否可以延长大鼠角膜同种异体移植物的存活。方法:近亲Fischer 344大鼠在携带抗CD4scFv cDNA(Lv-CD4scFv)的慢病毒载体转导了供体角膜3小时后,接受了来自Wistar-Furth供体的穿透性角膜移植,该慢病毒载体携带了报告基因增强的黄色荧光蛋白( LV-eYFP)或带有抗CD4 scFv cDNA(Ad-CD4scFv)的腺病毒载体。还进行了未修饰的对照。通过角膜清晰度评估移植物存活,并在组织学上证实排斥反应。结果:在器官培养的角膜中,在用腺病毒载体转导后第2天检测到抗CD4 scFv的表达,而在用慢病毒载体转导后第5天检测到了抗CD4 scFv的表达,并且是前者的10倍。术后15天,Ad-CD4scFv修饰的同种异体移植物比Lv-CD4scFv修饰的异种移植物观察到更多的炎症(p = 0.01)。未修饰的LV-eYFP和Ad-CD4scFv移植排斥反应的中位时间为第17天,而Lv-CD4scFv移植排斥反应的中位时间为22天(p≤0.018)。结论:与未修饰的Lv-eYFP和Ad-CD4scFv移植物相比,用携带抗CD4scFv cDNA的慢病毒载体转导的供体角膜显示出适度但显着的移植物存活延长。但是,在所有Lv-CD4scFv移植物中仍会出现排斥反应,这表明致敏作用可能已经延迟,但并没有被阻止。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号